Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

Our study is a step toward developing evidence-based clinical guidance to suggest apixaban as a safer choice than warfarin or rivaroxaban in the older AF population with HIV," the authors wrote.

Many people worry about the side effects of anticoagulant drugs like Eliquis or warfarin, but they prevent far more problems than they cause when prescribed appropriately. Many more strokes are ...

In the trial, patients taking Eliquis had fewer strokes than those who took warfarin. Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular ...

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.